CLINICAL_TRIALS
trial_result
· 2021-07-02
Clinical Trial Update: Phase 2 Herniorrhaphy Study for Opioid Elimination [Phase 2]
Summary
Phase 2 study evaluating HTX-011 (Zynrelef) for opioid-sparing postoperative pain control in herniorrhaphy; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Heron Therapeutics | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-07-02